Atlas Trials

A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome

Clinical trial NCT04244006 · UNKNOWN

Trial details

NCT number
NCT04244006
Sponsor
University Hospital, Toulouse
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Netherton Syndrome
Start date
2020-07-23
Primary completion
2024-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.